Fecal iron quantification in a randomized controlled trial of Lactiplantibacillus plantarum ATCC 202195 in newborns in Dhaka, Bangladesh

Read full text Summarise with VIRAT
Authors: Afreen Z. Khan, Anjan Kumar Roy, Huma Qamar, Lisa G. Pell, Karen M O’Callaghan, Shafiqul Alam Sarker, Abdullah A. Mahmud, Rashidul Haque, Sharmin Akter, Shamima Sultana, Daniel E. Roth, Rubhana Raqib
Cited by: 0
References: 42

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Probiotics may enhance host iron bioavailability, offering a strategy to address iron deficiency. Fecal iron may be a useful noninvasive biomarker of such effects in infants. OBJECTIVE: To examine the use of fecal iron quantification in a randomized placebo-controlled trial (RCT) of neonatal administration of Lactiplantibacillus plantarum ATCC 202195 (LP202195), with or without fructooligosaccharide (FOS), in Dhaka, Bangladesh. METHODS: Fecal iron quantification using atomic absorption spectrometry (AAS) was optimized using standards and reference materials, and pilot-tested using pooled stool aliquots (n = 32) from an observational cohort of young infants in Bangladesh (aged 0-64 days). The optimized AAS assay was then applied to individual stool samples collected at 14 days of age (n = 307) in a RCT in which newborns aged 0-4 days were randomly allocated to one of five groups: placebo, 1- or 7-day regimens of LP202195, with or without FOS. Serum ferritin was measured at 2 months postnatal age (n = 251). Effects of the 1- and 7-day LP202195 regimens were estimated using linear regression and expressed as mean percent differences relative to placebo, with 95% confidence intervals (95% CI). RESULTS: The optimized AAS fecal iron assay had acceptable accuracy (91%-99%), precision (within- and between-run coefficients of variation 0.05 for all). Similarly, there were no effects of LP202195 on serum ferritin at 2 months of age (P > 0.05 for all). CONCLUSIONS: Fecal iron quantification by AAS was valid and feasibly implemented in a trial of neonatal administration of L. plantarum ATCC 202195. However, the assay is resource-intensive and may not be more informative than conventional measures of iron status when studying the effects of probiotics/synbiotics on iron bioavailability. CLINICAL TRIAL REGISTRY: ClinicalTrials.gov identifier: NCT05180201.

Fields of Study & Subjects

Infant Nutrition and Health Probiotics and Fermented Foods Iron Metabolism and Disorders

Publication details

Journal / source
Nutrition
Volume
149
Pages
113221–113221
Publication date
28 March 2026
Language
EN